Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lamm W"" wg kryterium: Autor


Tytuł :
Incidence and Etiology of System Exchanges in Patients Receiving Extracorporeal Membrane Oxygenation.
Autorzy :
Nagler B; From the Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Hermann A; From the Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Robak O; From the Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Schellongowski P; From the Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Buchtele N; From the Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Bojic A; From the Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Schmid M; Department of Medicine III, Intensive Care Unit 13h1, Medical University of Vienna, Vienna, Austria.
Zauner C; Department of Medicine III, Intensive Care Unit 13h1, Medical University of Vienna, Vienna, Austria.
Winter MP; Department of Medicine II, Intensive Care Unit 13h3, Medical University of Vienna, Vienna, Austria.
Heinz G; Department of Medicine II, Intensive Care Unit 13h3, Medical University of Vienna, Vienna, Austria.
Ullrich R; Department of Anaesthesia, Critical Care and Pain Medicine, Medical University of Vienna, Vienna, Austria.
Kraft F; Department of Anaesthesia, Critical Care and Pain Medicine, Medical University of Vienna, Vienna, Austria.
Wiedemann D; Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Bernardi MH; Division of Cardiac Thoracic Vascular Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.
Staudinger T; From the Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Lamm W; From the Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2021 Jul 01; Vol. 67 (7), pp. 776-784.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long-term Respiratory Extracorporeal Membrane Oxygenation and Prognosis: A Retrospective Analysis.
Autorzy :
Bojic A; From the Department of Medicine I, Intensive Care Unit 13.i2, Medical University of Vienna, Vienna General Hospital, Waehringer Guertel, Vienna, Austria.
Schellongowski P
Robak O
Hermann A
Buchtele N
Nagler B
Lamm W
Staudinger T
Pokaż więcej
Źródło :
ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2021 Mar 01; Vol. 67 (3), pp. 345-352.
Typ publikacji :
Journal Article
MeSH Terms :
Treatment Outcome*
Extracorporeal Membrane Oxygenation/*methods
Respiratory Insufficiency/*therapy
Adult ; Extracorporeal Membrane Oxygenation/mortality ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/complications ; Prognosis ; Recovery of Function ; Respiratory Insufficiency/complications ; Retrospective Studies ; Risk Factors ; Time Factors
Czasopismo naukowe
Tytuł :
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
Autorzy :
Starzer AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Hamacher R; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
Tomasich E; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Feldmann K; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Hatziioannou T; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Traint S; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Lamm W; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Noebauer-Huhmann IM; Department of Biomedical Imaging and Image-guided Therapy, Division of General and Paediatric Radiology, Medical University of Vienna, Vienna, Austria.
Furtner J; Department of Biomedical Imaging and Image-guided Therapy, Division of General and Paediatric Radiology, Medical University of Vienna, Vienna, Austria.
Müllauer L; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Amann G; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Bauer S; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
Schildhaus HU; Institute of Pathology, University Hospital Essen, Essen, Germany.
Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Heller G; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria .
Brodowicz T; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect Management.
Autorzy :
Minichsdorfer C; Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna - General Hospital, Vienna, Austria.
Steinbrecher O; Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna - General Hospital, Vienna, Austria.
KÖlz M; Department of Pathology, Medical University of Vienna - General Hospital, Vienna, Austria.
Schmid M; Department of Radiation Oncology, Medical University of Vienna - General Hospital, Vienna, Austria.
Raderer M; Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna - General Hospital, Vienna, Austria.
Brodowicz T; Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna - General Hospital, Vienna, Austria.
Lamm W; Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna - General Hospital, Vienna, Austria; wolfgang.lamm@meduniwien.ac.at.
Pokaż więcej
Źródło :
In vivo (Athens, Greece) [In Vivo] 2021 Jan-Feb; Vol. 35 (1), pp. 385-391.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Neoplasms*/drug therapy
Osteosarcoma*/drug therapy
Sarcoma*/drug therapy
Adolescent ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Humans ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
CXCR4 PET imaging of mantle cell lymphoma using [ F]FDG-PET.
Autorzy :
Mayerhoefer ME; Dept. of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Austria.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.
Raderer M; Dept. of Internal Medicine I, Division of Oncology, Medical University of Vienna.
Lamm W; Dept. of Internal Medicine I, Division of Oncology, Medical University of Vienna.
Pichler V; Dept. of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria.
Pfaff S; Dept. of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria.
Weber M; Dept. of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Austria.
Kiesewetter B; Dept. of Internal Medicine I, Division of Oncology, Medical University of Vienna.
Hacker M; Dept. of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria.
Kazianka L; Dept. of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna.
Staber PB; Dept. of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna.
Wester HJ; Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany.
Rohrbeck J; Clinical Institute of Pathology, Medical University of Vienna.
Simonitsch-Klupp I; Clinical Institute of Pathology, Medical University of Vienna.
Haug A; Dept. of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria.
Pokaż więcej
Źródło :
Theranostics [Theranostics] 2021 Jan 01; Vol. 11 (2), pp. 567-578. Date of Electronic Publication: 2021 Jan 01 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
Czasopismo naukowe
Tytuł :
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI.
Autorzy :
Taghizadeh H; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Unseld M; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Spalt M; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Mader RM; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Müllauer L; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.; Clinical Institute of Pathology, Medical University Vienna, 1090 Vienna, Austria.
Fuereder T; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Raderer M; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Sibilia M; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, 1090 Vienna, Austria.
Hoda MA; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.; Department of Surgery, Institute of Cancer Research, Medical University of Vienna, 1090 Vienna, Austria.
Aust S; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.; Department of Obstetrics and Gynecology, Medical University of Vienna, 1090 Vienna, Austria.
Polterauer S; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.; Department of Obstetrics and Gynecology, Medical University of Vienna, 1090 Vienna, Austria.
Lamm W; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Bartsch R; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Preusser M; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
A KW; Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, 1090 Vienna, Austria.; Department of Medicine III, Gender Medicine Unit, Medical University of Vienna, 1090 Vienna, Austria.
Prager GW; Department of Medicine I, Division of Clinical Oncology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center Vienna, 1090 Vienna, Austria.
Pokaż więcej
Źródło :
Journal of personalized medicine [J Pers Med] 2020 Oct 23; Vol. 10 (4). Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic.
Autorzy :
Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Gansterer M; Faculty of Management and Economics, University of Klagenfurt, Klagenfurt, Austria.
Bathke AC; Faculty of Natural Sciences and Intelligent Data Analytics Lab Salzburg, University of Salzburg, Salzburg, Austria.
Trutschnig W; Faculty of Natural Sciences and Intelligent Data Analytics Lab Salzburg, University of Salzburg, Salzburg, Austria.
Hungerländer P; Faculty of Technical Sciences, University of Klagenfurt, Klagenfurt, Austria.
Berger JM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Kreminger J; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Starzer AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Strassl R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Schmidt R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Willschke H; Department of Anaesthesia and General Intensive Care, Medical University Vienna, Vienna, Austria.
Lamm W; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Raderer M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Gottlieb AD; Faculty of Mathematics, Wolfgang Pauli Institute, University of Vienna, Vienna, Austria.
Mauser NJ; Faculty of Mathematics, Wolfgang Pauli Institute, University of Vienna, Vienna, Austria.
Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Oct 20; Vol. 38 (30), pp. 3547-3554. Date of Electronic Publication: 2020 Aug 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Betacoronavirus/*isolation & purification
Coronavirus Infections/*diagnosis
Neoplasms/*virology
Pneumonia, Viral/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19 ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/drug therapy ; Pandemics ; SARS-CoV-2 ; Tertiary Care Centers ; Young Adult
Czasopismo naukowe
Tytuł :
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field.
Autorzy :
Marhold M; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria. Electronic address: .
Topakian T; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Agis H; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Bartsch R; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Berghoff AS; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Brodowicz T; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Fuereder T; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Ilhan-Mutlu A; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Kiesewetter B; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Krainer M; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Locker GJ; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Marosi C; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Prager G; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Schmidinger M; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Thallinger C; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Zöchbauer-Müller S; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Raderer M; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Preusser M; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Lamm W; Division of Oncology, Department for Medicine I, Medical University of Vienna, Wien, Austria.
Pokaż więcej
Źródło :
ESMO open [ESMO Open] 2020 Oct; Vol. 5 (5), pp. e000880.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna.
Autorzy :
Kiesewetter B; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Lamm W; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Neuper O; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Mayerhoefer ME; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
Simonitsch-Klupp I; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Raderer M; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2019 Oct; Vol. 37 (4), pp. 345-351. Date of Electronic Publication: 2019 Jul 28.
Typ publikacji :
Journal Article
MeSH Terms :
Angiogenesis Inhibitors/*therapeutic use
Antineoplastic Agents/*therapeutic use
Immunologic Factors/*therapeutic use
Lenalidomide/*therapeutic use
Lymphoma, B-Cell, Marginal Zone/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/administration & dosage ; Antineoplastic Agents/administration & dosage ; Austria/epidemiology ; Drug Evaluation ; Female ; Follow-Up Studies ; Humans ; Immunologic Factors/administration & dosage ; Kaplan-Meier Estimate ; Lenalidomide/administration & dosage ; Lymphoma, B-Cell, Marginal Zone/epidemiology ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/epidemiology ; Progression-Free Survival ; Remission Induction ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis.
Autorzy :
Kiesewetter B; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Lamm W; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Dolak W; Department of Medicine III, Clinical Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Lukas J; Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Mayerhoefer ME; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Weber M; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Schiefer AI; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Kornauth C; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Bayer G; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Simonitsch-Klupp I; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Raderer M; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2019 Aug; Vol. 186 (3), pp. 448-459. Date of Electronic Publication: 2019 May 24.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, B-Cell, Marginal Zone/*pathology
Polymerase Chain Reaction/*methods
Adult ; Aged ; Aged, 80 and over ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.
Autorzy :
Grilz E; Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Marosi C; Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Königsbrügge O; Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Riedl J; Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Posch F; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Lamm W; Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Lang IM; Clinical Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
Pabinger I; Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Ay C; Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2019 Aug; Vol. 17 (8), pp. 1335-1344. Date of Electronic Publication: 2019 Jun 17.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Arterial Occlusive Diseases/*blood
Fibrin Fibrinogen Degradation Products/*analysis
Neoplasms/*blood
P-Selectin/*blood
Thromboembolism/*blood
Aged ; Arterial Occlusive Diseases/diagnosis ; Arterial Occlusive Diseases/epidemiology ; Austria/epidemiology ; Biomarkers/blood ; Female ; Humans ; Incidence ; Leukocyte Count ; Male ; Middle Aged ; Neoplasms/diagnosis ; Neoplasms/epidemiology ; Neutrophils ; Predictive Value of Tests ; Risk Assessment ; Risk Factors ; Thromboembolism/diagnosis ; Thromboembolism/epidemiology
Czasopismo naukowe
Tytuł :
TRANSFORMED MUCOSA‐ASSOCIATED LYMPHOID TISSUE LYMPHOMAS: A SINGLE INSTITUTION RETROSPECTIVE STUDY INCLUDING PCR‐BASED CLONALITY ANALYSIS.
Autorzy :
Kiesewetter, B.
Lamm, W.
Dolak, W.
Lukas, J.
Mayerhoefer, M.E.
Weber, M.
Kornauth, C.
Schiefer, A.I.
Bayer, G.
Simonitsch‐Klupp, I.
Raderer, M.
Pokaż więcej
Temat :
MUCOSA-associated lymphoid tissue lymphoma
LYMPHOID tissue
LYMPHOMAS
RETROSPECTIVE studies
Źródło :
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p264-264, 1p
Czasopismo naukowe
Tytuł :
FIRST LINE SYSTEMIC TREATMENT IN MUCOSA‐ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA NOT ELIGIBLE FOR H. PYLORI ERADICATION – DO WE NEED CHEMOTHERAPY?
Autorzy :
Kiesewetter, B.
Lamm, W.
Mayerhoefer, M.E.
Dolak, W.
Lukas, J.
Simonitsch‐Klupp, I.
Raderer, M.
Pokaż więcej
Temat :
MUCOSA-associated lymphoid tissue lymphoma
THERAPEUTICS
LYMPHOID tissue
LYMPHOMAS
CHEMOTHERAPY (Cancer)
MALT
Źródło :
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p449-450, 2p
Czasopismo naukowe
Tytuł :
Successful retreatment with 3-week rituximab-bendamustine with high-dose dexamethasone in patients with relapsed/refractory mantle cell lymphoma.
Autorzy :
Lamm W; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria. wolfgang.lamm@meduniwien.ac.at.
Kiesewetter B; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Puhr H; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Dolak W; Department of Medicine III, Clinical Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Mayerhöfer ME; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Raderer M; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2019 Jun; Vol. 98 (6), pp. 1519-1520. Date of Electronic Publication: 2018 Dec 13.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Lymphoma, Mantle-Cell/*drug therapy
Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bendamustine Hydrochloride/administration & dosage ; Dexamethasone/administration & dosage ; Drug Evaluation ; Drug Resistance, Neoplasm ; Female ; Humans ; Male ; Remission Induction ; Retreatment ; Retrospective Studies ; Risk ; Rituximab/administration & dosage
Raport
Tytuł :
Propofol-based sedation does not negatively influence oxygenator running time compared to midazolam in patients with extracorporeal membrane oxygenation.
Autorzy :
Lamm W; 1 Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Nagler B; 1 Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Hermann A; 1 Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Robak O; 1 Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Schellongowski P; 1 Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Buchtele N; 1 Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Bojic A; 1 Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Schmid M; 2 Department of Medicine III, Intensive Care Unit 13h1, Medical University of Vienna, Vienna, Austria.
Zauner C; 2 Department of Medicine III, Intensive Care Unit 13h1, Medical University of Vienna, Vienna, Austria.
Heinz G; 3 Department of Medicine II, Intensive Care Unit 13h3, Medical University of Vienna, Vienna, Austria.
Ullrich R; 4 Department of Anaesthesia, Critical Care and Pain Medicine, Medical University of Vienna, Vienna, Austria.
Staudinger T; 1 Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
The International journal of artificial organs [Int J Artif Organs] 2019 May; Vol. 42 (5), pp. 233-240. Date of Electronic Publication: 2019 Feb 28.
Typ publikacji :
Journal Article
MeSH Terms :
Extracorporeal Membrane Oxygenation*/adverse effects
Extracorporeal Membrane Oxygenation*/instrumentation
Extracorporeal Membrane Oxygenation*/methods
Midazolam*/administration & dosage
Midazolam*/adverse effects
Oxygenators*
Conscious Sedation/*methods
Adult ; Aged ; Equipment Failure ; Female ; Humans ; Hypnotics and Sedatives/administration & dosage ; Male ; Middle Aged ; Propofol/administration & dosage ; Propofol/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
Autorzy :
Kiesewetter B; Division of Oncology, Department of Internal Medicine I, Medical University Vienna, Vienna, Austria.; Neuroendocrine Tumor Unit, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.
Duan H; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, Austria.
Lamm W; Division of Oncology, Department of Internal Medicine I, Medical University Vienna, Vienna, Austria.; Neuroendocrine Tumor Unit, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.
Haug A; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, Austria.
Riss P; Section of Endocrine Surgery, Division of General Surgery, Department of Surgery, Medical University Vienna, Vienna, Austria.; Neuroendocrine Tumor Unit, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.
Selberherr A; Section of Endocrine Surgery, Division of General Surgery, Department of Surgery, Medical University Vienna, Vienna, Austria.; Neuroendocrine Tumor Unit, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.
Scheuba C; Section of Endocrine Surgery, Division of General Surgery, Department of Surgery, Medical University Vienna, Vienna, Austria.; Neuroendocrine Tumor Unit, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.
Raderer M; Division of Oncology, Department of Internal Medicine I, Medical University Vienna, Vienna, Austria .; Neuroendocrine Tumor Unit, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
The oncologist [Oncologist] 2019 Feb; Vol. 24 (2), pp. 255-258. Date of Electronic Publication: 2018 Aug 31.
Typ publikacji :
Journal Article
MeSH Terms :
Antidiarrheals/*therapeutic use
Malignant Carcinoid Syndrome/*drug therapy
Ondansetron/*therapeutic use
Serotonin Antagonists/*therapeutic use
Somatostatin/*analogs & derivatives
Administration, Oral ; Aged ; Antidiarrheals/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Ondansetron/pharmacology ; Retrospective Studies ; Serotonin Antagonists/pharmacology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies